Phase I clinical trial of continuous infusion of tyroserleutide in patients with advanced hepatocellular carcinoma
Latest Information Update: 02 May 2012
At a glance
- Drugs Tyroserleutide (Primary)
- Indications Liver cancer
- Focus Adverse reactions
- Sponsors Shenzhen Kangzhe Pharmaceutical
- 02 May 2012 New trial record
- 04 Apr 2012 Results presented at the 103rd Annual Meeting of the American Association for Cancer Research.